• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Deadline Approaching: Apply for the Fierce AI Innovation Awards
calendar
Biotech

Parabilis’ upsized $670M IPO breaks new record for biotechs

Parabilis Medicines’ IPO has lived up to the hype—securing $670 million for the largest listing in the biotech sector’s history.
James Waldron Jun 10, 2026 4:36am
Novo Nordisk

ADA: Novo CSO says ‘jury still out’ on CagriSema v. retatrutide

Jun 10, 2026 11:10am
FranchiseKeyvisualsOncologyLevel2Digital-nonepng

Could engaging the immune system improve AML outcomes?

Brought to you by Ipsen
Sanofi

Sanofi halts phase 3 autoimmune trial early over lackluster data

Jun 10, 2026 4:25am
Charles River Boston Massachusetts

Charles River CEO shares ‘the next big transition’ in CRO space

Jun 10, 2026 1:05pm
Brown mouse nibbling a cookie

GLP-1s may combat depression through a mood-boosting gut microbe

Jun 10, 2026 11:00am
More News

Big Pharma-backed SonoThera sounds off with $125M series B

Jun 10, 2026 10:48am

Ethyreal Bio raises $101M, joining biotechs gunning for Tepezza

Jun 10, 2026 9:35am

Fierce Biotech Fundraising Tracker '26: Ethyreal, City & more

Jun 10, 2026 9:30am

Novartis sticks 2nd deal with Orionis, this one worth up to $1.4B

Jun 10, 2026 8:21am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings